HD Preisler
- Hematology top 1%
- Acute Myeloid Leukemia Research 34
- Chronic Myeloid Leukemia Treatments 5
- Hematopoietic Stem Cell Transplantation 5
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research 8
-
- Acute Lymphoblastic Leukemia research 18
- Oncology top 10%
- Neutropenia and Cancer Infections 8
-
- Retinoids in leukemia and cellular processes 5
-
- Hematological disorders and diagnostics 4
HD Preisler
57 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 80
- Hematology 862
- Genetics 191
- Public Health, Environmental and Occupational Health 420
- Oncology 300
- Molecular Biology 447
Countries citing papers authored by HD Preisler
This map shows the geographic impact of HD Preisler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by HD Preisler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites HD Preisler more than expected).
Fields of papers citing papers by HD Preisler
This network shows the impact of papers produced by HD Preisler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by HD Preisler. The network helps show where HD Preisler may publish in the future.
Co-authorship network
The 25 scholars most cited alongside HD Preisler, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1993 | 2 | |
| 2 | 1992 | 1 | |
| 3 | 1991 | 3 | |
| 4 | 1991 | 13 | |
| 5 | 1989 | 60 | |
| 6 | 1988 | 15 | |
| 7 | 1988 | 4 | |
| 8 | 1987 | 11 | |
| 9 | 1987 | 10 | |
| 10 | 1987 | 15 | |
| 11 | 1987 | 7 | |
| 12 | 1986 | 6 | |
| 13 | 1985 | 3 | |
| 14 | 1985 | 1 | |
| 15 | 1984 | 3 | |
| 16 | 1982 | 21 | |
| 17 | 1982 | 19 | |
| 18 | 1982 | 1 | |
| 19 | Combination chemotherapy plus methanol extracted residue of bacillus Calmette-Guérin or Corynebacterium parvum in stage III lung cancer. | 1978 | 12 |
| 20 | 1976 | 48 |
About HD Preisler
HD Preisler is a scholar working on Hematology, Genetics, Public Health, Environmental and Occupational Health, Oncology and Immunology, having authored 58 papers that have together received 1.2k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (34 papers), Acute Lymphoblastic Leukemia research (18 papers), Chronic Lymphocytic Leukemia Research (8 papers), Neutropenia and Cancer Infections (8 papers), Chronic Myeloid Leukemia Treatments (5 papers), Retinoids in leukemia and cellular processes (5 papers), Hematopoietic Stem Cell Transplantation (5 papers) and Hematological disorders and diagnostics (4 papers). The work is most often cited by research in Hematology (862 citations), Genetics (191 citations), Public Health, Environmental and Occupational Health (420 citations), Oncology (300 citations) and Molecular Biology (447 citations). HD Preisler has collaborated with scholars based in United States, Italy and Jamaica. Frequent co-authors include Azra Raza, Sigurður Björnsson, Abbas Raza, Henderson Es, Creaven Pj, Youcef M. Rustum, Arnold I. Freeman, S Banavali, Richard A. Larson and George P. Browman. Their work appears in journals such as Blood, British Journal of Haematology, British Journal of Cancer, Journal of Immunotherapy and Differentiation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.